Daehan New Pharm Co. Ltd (054670) — Free Cash Flow Generation Index
Daehan New Pharm Co. Ltd (054670) has a Free Cash Flow Generation Index of -1.61x as of September 2025. Free cash flow of ₩-7.11 Billion represents -2% of operating cash flow (₩4.43 Billion). Read Daehan New Pharm Co. Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Daehan New Pharm Co. Ltd Free Cash Flow Generation Index (2011–2024)
Historical FCF Generation Index trend for Daehan New Pharm Co. Ltd across 12 annual periods. Explore 054670 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Daehan New Pharm Co. Ltd (2011–2024)
Year-by-year Free Cash Flow Generation Index for Daehan New Pharm Co. Ltd. For the full company profile including market capitalisation, see Daehan New Pharm Co. Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.81x | ₩-15.34 Billion | ₩18.95 Billion | ₩34.26 Billion | ▼ -507.2% |
| 2023 | 0.20x | ₩2.50 Billion | ₩12.57 Billion | ₩9.93 Billion | ▼ -73.6% |
| 2022 | 0.75x | ₩10.73 Billion | ₩14.25 Billion | ₩3.51 Billion | ▲ +111.4% |
| 2021 | 0.36x | ₩5.90 Billion | ₩16.58 Billion | ₩10.55 Billion | ▲ +28.9% |
| 2020 | 0.28x | ₩3.74 Billion | ₩13.55 Billion | ₩9.46 Billion | ▼ -37.9% |
| 2019 | 0.44x | ₩10.18 Billion | ₩22.89 Billion | ₩9.08 Billion | ▼ -59.0% |
| 2018 | 1.08x | ₩22.21 Billion | ₩20.47 Billion | ₩1.73 Billion | ▼ -28.8% |
| 2016 | 1.52x | ₩13.32 Billion | ₩8.75 Billion | ₩4.57 Billion | ▲ +1.8% |
| 2015 | 1.50x | ₩11.67 Billion | ₩7.80 Billion | ₩3.86 Billion | ▼ -10.4% |
| 2014 | 1.67x | ₩16.71 Billion | ₩10.02 Billion | ₩6.69 Billion | ▼ -71.4% |
| 2012 | 5.83x | ₩1.50 Billion | ₩256.82 Million | ₩1.24 Billion | ▲ +330.9% |
| 2011 | 1.35x | ₩4.62 Billion | ₩3.42 Billion | ₩1.20 Billion | — |